KMT2A and acute myeloid leukemia: 41 genes and 21 miRNAs with MLL-AF9-dependent expression were identified in endogenous MLL-AF9 knockdown THP1 cells, derived from an AML patient [77, 78], including mediators of MLL-AF9 leukemogenic effects.